GILEAD SCIENCES, INC. Loss Contingency, Patents Allegedly Infringed, Number
GILEAD SCIENCES, INC. (GILD) reported Loss Contingency, Patents Allegedly Infringed, Number of 2 patent for the 1-month period ending 2026-01-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency, Quantities
us-gaap:LossContingencyPatentsAllegedlyInfringedNumber · last filed 2026-08-06
- 2026-01-31: Loss Contingency, Patents Allegedly Infringed, Number 1 month 2.00 patent.
- 2025-06-30: Loss Contingency, Patents Allegedly Infringed, Number 1 month 6.00 patent.
- 2023-11-30: Loss Contingency, Patents Allegedly Infringed, Number 1 month 2.00 patent.
- 2022-03-31: Loss Contingency, Patents Allegedly Infringed, Number 1 month 4.00 patent; Loss Contingency, Patents Allegedly Infringed, Number 1 month as first filed 3.00 patent.
| Period end | Loss Contingency, Patents Allegedly Infringed, Number 1 month | Loss Contingency, Patents Allegedly Infringed, Number 1 month as first filed |
|---|---|---|
| 2026-01-31 | 2.00 patent 10-Q · filed 2026-08-06 | |
| 2025-06-30 | 6.00 patent 10-Q · filed 2026-05-07 | |
| 2023-11-30 | 2.00 patent 10-K · filed 2026-02-24 | |
| 2022-03-31 | 4.00 patent 10-K · filed 2026-02-24 | 3.00 patent 10-Q · filed 2022-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |